Yale University New haven, CT: Researchers at Yale have identified a possible treatment for Duchenne muscular dystrophy (DMD), a rare genetic disease for which there is currently no cure or treatment, by targeting an enzyme that had been considered "undruggable." The finding appears in the Aug. 25 edition of Science Signaling. DMD is the most common form of muscular dystrophy, a disease that...
Read Full StoryDisease-prevention-and-treatment
Drugging the undruggable: Yale finds treatment path for muscular dystrophy
